774 A phase 1 study exploring the safety and tolerability of the small molecule PD-L1 inhibitor, INCB086550, in patients with select advanced tumors
Christophe Le Tourneau,Sarina Piha-Paul,Hans Prenen,Brant Delafontaine,David Pinato,Armando Santoro,Rebecca Kristeleit,Kristen Spencer,Tara Gangadhar,Howard Burris,Nuria Kotecki,Bristi Basu,Donna Graham,Anna Maria Di Giacomo,Solmaz Sahebjam,Massimo Di Nicola,Carlos Gomez-Roca,Pascale Tomasini,Paolo Ascierto,Giuseppe Curigliano,Thomas Karasic,Ryan Geschwindt,Jeannie Daniel,Eric Van Cutsem Regular and Young Investigator Award Abstracts（2022）
关键词
select advanced tumors
AI 理解论文
溯源树
样例
